194 related articles for article (PubMed ID: 29159873)
1. Orthopaedic manifestations within the 22q11.2 Deletion syndrome: A systematic review.
Homans JF; Tromp IN; Colo D; Schlösser TPC; Kruyt MC; Deeney VFX; Crowley TB; McDonald-McGinn DM; Castelein RM
Am J Med Genet A; 2018 Oct; 176(10):2104-2120. PubMed ID: 29159873
[TBL] [Abstract][Full Text] [Related]
2. The role of 22q11.2 deletion syndrome in the relationship between congenital heart disease and scoliosis.
Homans JF; de Reuver S; Heung T; Silversides CK; Oechslin EN; Houben ML; McDonald-McGinn DM; Kruyt MC; Castelein RM; Bassett AS
Spine J; 2020 Jun; 20(6):956-963. PubMed ID: 31958577
[TBL] [Abstract][Full Text] [Related]
3. Club foot in association with the 22q11.2 deletion syndrome: An observational study.
Homans JF; Crowley TB; Chen E; McGinn DE; Deeney VFX; Sakkers RJB; Davidson RS; Castelein RM; McDonald-McGinn DM
Am J Med Genet A; 2018 Oct; 176(10):2135-2139. PubMed ID: 30380189
[TBL] [Abstract][Full Text] [Related]
4. Scoliosis in association with the 22q11.2 deletion syndrome: an observational study.
Homans JF; Baldew VGM; Brink RC; Kruyt MC; Schlösser TPC; Houben ML; Deeney VFX; Crowley TB; Castelein RM; McDonald-McGinn DM
Arch Dis Child; 2019 Jan; 104(1):19-24. PubMed ID: 29627765
[TBL] [Abstract][Full Text] [Related]
5. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review.
Mosheva M; Korotkin L; Gur RE; Weizman A; Gothelf D
Eur Child Adolesc Psychiatry; 2020 Aug; 29(8):1035-1048. PubMed ID: 30949827
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review.
de Boer J; Boot E; van Gils L; van Amelsvoort T; Zinkstok J
Am J Med Genet A; 2019 Nov; 179(11):2292-2306. PubMed ID: 31407842
[TBL] [Abstract][Full Text] [Related]
8. Dental management of a patient with 22q11.2 deletion syndrome (22q11.2DS).
AlQarni MA; Alharbi A; Merdad L
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30232069
[TBL] [Abstract][Full Text] [Related]
9. Reproductive Health Issues for Adults with a Common Genomic Disorder: 22q11.2 Deletion Syndrome.
Chan C; Costain G; Ogura L; Silversides CK; Chow EW; Bassett AS
J Genet Couns; 2015 Oct; 24(5):810-21. PubMed ID: 25579115
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes.
Zarchi O; Diamond A; Weinberger R; Abbott D; Carmel M; Frisch A; Michaelovsky E; Gruber R; Green T; Weizman A; Gothelf D
Eur Psychiatry; 2014 May; 29(4):203-10. PubMed ID: 24054518
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of fatigue in adults with a 22q11.2 deletion syndrome.
Vergaelen E; Claes S; Kempke S; Swillen A
Am J Med Genet A; 2017 Apr; 173(4):858-867. PubMed ID: 28190295
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness and tolerability of pharmacotherapy for psychosis in 22q11.2 Deletion Syndrome: A systematic review.
Tanham M; Chen R; Warren N; Heussler H; Scott JG
Aust N Z J Psychiatry; 2024 May; 58(5):393-403. PubMed ID: 38383990
[TBL] [Abstract][Full Text] [Related]
13. [22q11.2 microdeletion syndrome: Analysis of the care pathway before the genetic diagnosis].
Ingrao T; Lambert L; Valduga M; Bosser G; Albuisson E; Leheup B
Arch Pediatr; 2017 Nov; 24(11):1067-1075. PubMed ID: 28967605
[TBL] [Abstract][Full Text] [Related]
14. Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study.
von Scheibler ENMM; van der Valk Bouman ES; Nuijts MA; Bauer NJC; Berendschot TTJM; Vermeltfoort P; Bok LA; van Eeghen AM; Houben ML; van Amelsvoort TAMJ; Boot E; van Egmond-Ebbeling MB
Am J Med Genet A; 2022 Feb; 188(2):569-578. PubMed ID: 34773366
[TBL] [Abstract][Full Text] [Related]
15. [Graves disease and IgA deficiency as manifestations of 22q11.2 deletion syndrome].
Silva JM; Silva CP; Melo FF; Silva LA; Utagawa CY
Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):572-7. PubMed ID: 20857064
[TBL] [Abstract][Full Text] [Related]
16. [22q11.2DS Syndrome as a Genetic Subtype of Schizophrenia].
Huertas-Rodríguez CK; Payán-Gómez C; Forero-Castro RM
Rev Colomb Psiquiatr; 2015; 44(1):50-60. PubMed ID: 26578219
[TBL] [Abstract][Full Text] [Related]
17. Association of airway abnormalities with 22q11.2 deletion syndrome.
Sacca R; Zur KB; Crowley TB; Zackai EH; Valverde KD; McDonald-McGinn DM
Int J Pediatr Otorhinolaryngol; 2017 May; 96():11-14. PubMed ID: 28390597
[TBL] [Abstract][Full Text] [Related]
18. Congenital diaphragmatic hernia in 22q11.2 deletion syndrome.
Unolt M; DiCairano L; Schlechtweg K; Barry J; Howell L; Kasperski S; Nance M; Adzick NS; Zackai EH; McDonald-McGinn DM
Am J Med Genet A; 2017 Jan; 173(1):135-142. PubMed ID: 27682988
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
Butcher NJ; Marras C; Pondal M; Rusjan P; Boot E; Christopher L; Repetto GM; Fritsch R; Chow EWC; Masellis M; Strafella AP; Lang AE; Bassett AS
Brain; 2017 May; 140(5):1371-1383. PubMed ID: 28369257
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
